3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
16
Carcinoma, Renal Cell
13
Carcinoma, Non-Small-Cell Lung
7
Neoplasm Metastasis
6
Clear-cell metastatic renal cell carcinoma
6
Lung Neoplasms
5
Prostatic Neoplasms
4
Brain Neoplasms
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Ovarian Neoplasms
3
Myelodysplastic Syndromes
3
Histiocytoma, Malignant Fibrous
3
Carcinoma, Transitional Cell
3
Carcinoma, Basal Cell
3
Urogenital Neoplasms
2
Ureteral Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Rectal Neoplasms
2
Penile Neoplasms
2
Nasopharyngeal Carcinoma
2
Meningioma
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Hematologic Neoplasms
2
Glioblastoma
2
Carcinoma, Merkel Cell
2
Interventions
Cyclophosphamide
47
Rituximab
31
fludarabine
29
Specimen Handling
13
Magnetic Resonance Spectroscopy
13
Doxorubicin
13
pirtobrutinib
11
Vincristine
11
Prednisone
11
fludarabine phosphate
10
Immunotherapy, Adoptive
10
Etoposide
10
Bendamustine Hydrochloride
10
obinutuzumab
8
Lenalidomide
8
Biopsy
8
venetoclax
7
polatuzumab vedotin
7
glofitamab
7
zanubrutinib
6
pembrolizumab
6
Dexamethasone
6
tafasitamab
5
ibrutinib
5
etoposide phosphate
5
acalabrutinib
5
Leukapheresis
5
tazemetostat
4
loncastuximab tesirine
4
Nivolumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
CTLA-4 Antigen
×
1 year
×
Clear all
No trials found.